Corcept Therapeutics Incorporated (CORT) is listed on NASDAQ in Pharmaceutical Stocks. It is $113.77, -2.70%, with a $12.3B market cap. RSI is 55.4, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.4 Neutral
Market Cap $12.3B
Volume 665.1K
Fundamentals — 10-Q Q2 2026
Revenue $421.1M
Net Income $11.2M
EPS $0.09
Gross Margin 98.4%
Operating Margin -2.0%
Net Margin 2.7%
P/E Ratio 1264.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Park Kimberly | Insider | Sell | 26,685 | $122.55 | $3.3M | 2026 Aug 26 |
| Maduck Sean | Insider | Sell | 30,955 | $125.58 | $3.9M | 2026 Aug 25 |
| Mahoney David L | Insider | Sell | 103,606 | $118.25 | $12.3M | 2026 Aug 18 |
| Robb Gary Charles | Chief Business Officer | Sell | 10,000 | $116.26 | $1.2M | 2026 Aug 17 |
| Maduck Sean | Insider | Sell | 3,664 | $114.49 | $419,491 | 2026 Aug 14 |
| Wilson James N | Insider | Sell | 10,000 | $111.43 | $1.1M | 2026 Aug 14 |
| Maduck Sean | Insider | Sell | 1,031 | $114.52 | $118,068 | 2026 Aug 10 |
| Guyer William | Chief Development Officer | Sell | 16,300 | $113.43 | $1.8M | 2026 Aug 10 |
| Guyer William | Chief Development Officer | Sell | 3,700 | $113.12 | $418,562 | 2026 Aug 4 |
| Maduck Sean | Insider | Sell | 20,305 | $114.70 | $2.3M | 2026 Aug 3 |
| Lyon Joseph Douglas | Insider | Sell | 1,540 | $114.16 | $175,806 | 2026 Aug 3 |
| Mokari Atabak | Chief Financial Officer | Sell | 80,000 | $114.71 | $9.2M | 2026 Jul 30 |
| Wilson James N | Insider | Sell | 10,000 | $88.30 | $882,986 | 2026 Jul 15 |
| Mokari Atabak | Chief Financial Officer | Sell | 40,000 | $87.71 | $3.5M | 2026 Jul 15 |
| Guyer William | Chief Development Officer | Sell | 20,000 | $93.13 | $1.9M | 2026 Jul 7 |
| Maduck Sean | Insider | Sell | 25,000 | $88.35 | $2.2M | 2026 Jul 1 |
| Mahoney David L | Insider | Sell | 20,000 | $84.53 | $1.7M | 2026 Jun 17 |
| Wilson James N | Insider | Sell | 10,000 | $83.20 | $832,049 | 2026 Jun 16 |
| Mokari Atabak | Chief Financial Officer | Sell | 40,000 | $81.15 | $3.2M | 2026 Jun 15 |
| Guyer William | Chief Development Officer | Sell | 20,000 | $70.60 | $1.4M | 2026 Jun 2 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $84.95 | 54.8 | $12.0B |
| | $18.03 | 47.2 | $6.3B |
| | $32.15 | 38.6 | $3.8B |
| | $76.62 | 35.2 | $15.0B |
| | $34.78 | 68.0 | $3.9B |
Take CORT further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put CORT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Corcept Therapeutics Incorporated next reports.
Set alerts on CORT
Get notified when Corcept Therapeutics Incorporated hits your price targets or technical conditions are met.
Get Started Free